Drug Manufacturers—Specialty & Generic Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3414 |  LFCR Lifecore Biomedical, Inc. - Common Stock | 6.43 USD | -0.16% | -1.83% | +60.75% | -3.45% | 243.40 M USD | ||
| 3434 |  SIGA SIGA Technologies Inc. - Common Stock | 3.28 USD | +0.61% | -3.53% | +6.84% | -61.41% | 235.67 M USD | ||
| 3476 |  AKBA Akebia Therapeutics, Inc. - Common Stock | 0.81 USD | -6.90% | -8.99% | -14.74% | -31.36% | 224.46 M USD | ||
| 3633 |  DERM Journey Medical Corporation - Common Stock | 5.95 USD | 0.00% | -12.88% | -19.38% | -20.67% | 167.94 M USD | ||
| 3644 |  ORGO Organogenesis Holdings Inc. - Class A | 1.28 USD | -3.03% | -8.57% | -18.47% | -70.16% | 164.70 M USD | ||
| 3755 |  CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 1.30 USD | -1.52% | -17.72% | -41.18% | +19.27% | 130.33 M USD | ||
| 3757 |  OGI Organigram Global Inc. - Common Shares | 0.95 USD | -1.04% | -3.06% | -12.84% | -33.57% | 127.74 M USD | ||
| 3843 |  CPIX Cumberland Pharmaceuticals Inc. - Common Stock | 6.98 USD | +1.31% | -9.82% | +11.68% | +97.73% | 104.58 M USD | ||
| 3972 |  CTOR Citius Oncology, Inc. - Common Stock | 0.84 USD | -2.33% | -16.00% | -10.64% | -27.59% | 78.10 M USD | ||
| 4122 |  TLPH Talphera, Inc. - Common Stock | 1.08 USD | +2.86% | -2.70% | -10.00% | -14.96% | 56.06 M USD | ||
| 4129 |  INCR Intercure Ltd. - ordinary shares | 5.02 USD | -2.14% | -6.69% | -4.02% | +198.81% | 54.90 M USD | ||
| 4135 |  ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 1.15 USD | -0.86% | -8.73% | -25.81% | -52.87% | 54.50 M USD | ||
| 4247 |  SCYX SCYNEXIS, Inc. - Common Stock | 4.22 USD | -11.72% | -20.68% | -12.45% | +427.50% | 41.99 M USD | ||
| 4254 |  CPHI China Pharma Holdings, Inc. Common Stock | 0.96 USD | +9.09% | +50.00% | +18.52% | +45.45% | 41.30 M USD | ||
| 4264 |  IXHL Incannex Healthcare Inc. - Common Stock | 3.20 USD | +0.63% | -3.61% | -0.93% | +644.19% | 40.14 M USD | ||
| 4348 |  RMTI Rockwell Medical, Inc. - Common Stock | 8.02 USD | -2.43% | -5.76% | +2.17% | +568.33% | 32.32 M USD | ||
| 4403 |  SHPH Shuttle Pharmaceuticals Holdings, Inc. - common stock | 5.56 USD | +18.05% | +36.27% | +62.57% | +414.81% | 26.49 M USD | ||
| 4444 |  TXMD TherapeuticsMD, Inc. - Common Stock | 2.01 USD | +0.50% | -1.47% | -5.19% | +84.40% | 23.26 M USD | ||
| 4452 |  AYTU Aytu BioPharma, Inc. - Common Stock | 2.05 USD | 0.00% | -1.44% | -4.65% | -19.61% | 22.28 M USD | ||
| 4587 |  BFRI Biofrontera Inc. - Common Stock | 0.92 USD | -2.13% | -12.38% | -39.87% | -9.80% | 13.66 M USD |
Noticias Drug Manufacturers—Specialty & Generic Stocks
Jefferies rebaja la calificación de Pacira Pharmaceuticals por el acuerdo con Viatris
Informe de resultados: Tilray registra ingresos récord en el primer trimestre de 2027 mientras sus acciones caen
La acción de Pacira Pharmaceuticals alcanza su un máximo de 52 semanas en 36,32 dólares
Biofrontera solicita ampliar el uso de Ameluz para queratosis actínicas
China SXT Pharmaceuticals anuncia una oferta de acciones por 12 millones de dólares
¿Por qué se dispara hoy la acción de Pacira BioSciences?
Viatris adquirirá Pacira BioSciences por 1.650 millones de dólares
Gainers Drug Manufacturers—Specialty & Generic Stocks
Losers Drug Manufacturers—Specialty & Generic Stocks
 SXTC China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares | 0.34 | -87.99% |
 SBFM Sunshine Biopharma Inc. - Common stock | 0.43 | -38.57% |
 BFRIW Biofrontera Inc. - Warrants | 0.0070 | -35.78% |
 SBFMW Sunshine Biopharma Inc. - Warrant | 0.0300 | -23.08% |
SCYX SCYNEXIS, Inc. - Common Stock | 4.22 | -11.72% |
 IMCC IM Cannabis Corp. - Common Shares | 1.72 | -9.47% |
 AKAN Akanda Corp. - Common Shares | 1.78 | -7.77% |
AKBA Akebia Therapeutics, Inc. - Common Stock | 0.81 | -6.90% |